Figure 2From: Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial Study flowchart on management of renal dysfunction and hyperkalaemia. eGFR, estimated glomerular filtration rate; K+, serum potassium concentration.Back to article page